Literature DB >> 18412144

Quantification of myocardial iron overload by cardiovascular magnetic resonance imaging T2* and review of the literature.

Ashok K Kondur1, Tao Li, Peter Vaitkevicius, Luis Afonso.   

Abstract

Heart failure due to myocardial iron overload remains the leading cause of death in patients with transfusion-dependent anemias. Iron overload-induced cardiomyopathy is reversible if intensive chelation therapy is instituted on time. Thus, early detection of myocardial iron deposition is imperative to prevent overt heart failure. Conventional cardiac monitoring, including physical examination, electrocardiography, echocardiography or serum ferritin levels fail to predict manifest or subclinical myocardial involvement resulting from iron overload. Cardiovascular magnetic resonance imaging T2* (cMRI-T2*, pronounced T2 star) times correlate well with myocardial iron levels. This timely review focuses on the utility of cMRI-T2*, for the preclinical detection of myocardial iron overload and monitoring of myocardial iron content during chelation therapy. 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18412144      PMCID: PMC6653638          DOI: 10.1002/clc.20310

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  11 in total

1.  MRI guided iron assessment and oral chelator use improve iron status in thalassemia major patients.

Authors:  Diana X Nichols-Vinueza; Matthew T White; Andrew J Powell; Puja Banka; Ellis J Neufeld
Journal:  Am J Hematol       Date:  2014-04-10       Impact factor: 10.047

2.  [Clinical indications for the use of cardiac MRI. By the SIRM Study Group on Cardiac Imaging].

Authors:  E Di Cesare; F Cademartiri; I Carbone; A Carriero; M Centonze; F De Cobelli; R De Rosa; P Di Renzi; A Esposito; R Faletti; R Fattori; M Francone; A Giovagnoni; L La Grutta; G Ligabue; L Lovato; R Marano; M Midiri; A Romagnoli; V Russo; F Sardanelli; L Natale; J Bogaert; A De Roos
Journal:  Radiol Med       Date:  2012-11-26       Impact factor: 3.469

3.  Motion-robust cardiac B1+ mapping at 3T using interleaved bloch-siegert shifts.

Authors:  Sebastian Weingärtner; Fabian Zimmer; Gregory J Metzger; Kâmil Uğurbil; Pierre-Francois Van de Moortele; Mehmet Akçakaya
Journal:  Magn Reson Med       Date:  2016-09-07       Impact factor: 4.668

Review 4.  Imaging of early modification in cardiomyopathy: the doxorubicin-induced model.

Authors:  Mohamed Aissiou; Delphine Périé; Farida Cheriet; Nagib S Dahdah; Caroline Laverdière; Daniel Curnier
Journal:  Int J Cardiovasc Imaging       Date:  2013-06-07       Impact factor: 2.357

5.  Evaluation of electrocardiography, echocardiography and cardiac T2* for cardiac complications in beta thalassemia major.

Authors:  Fadime Ersoy Dursun; Gönül Açıksarı; Serçin Özkök; Onur İncealtın
Journal:  Int J Cardiovasc Imaging       Date:  2021-10-08       Impact factor: 2.357

6.  Magnetic Resonance Imaging of Non-ischemic Cardiomyopathies: A Pictorial Essay.

Authors:  Cristina I Olivas-Chacon; Carola Mullins; Kevan Stewart; Nassim Akle; Jesus E Calleros; Luis R Ramos-Duran
Journal:  J Clin Imaging Sci       Date:  2015-06-30

Review 7.  Imaging Metabolically Active Fat: A Literature Review and Mechanistic Insights.

Authors:  Joseph Frankl; Amber Sherwood; Deborah J Clegg; Philipp E Scherer; Orhan K Öz
Journal:  Int J Mol Sci       Date:  2019-11-05       Impact factor: 5.923

8.  Free-breathing T2* mapping for MR myocardial iron assessment at 3 T.

Authors:  E E Nazarova; G V Tereshchenko; D A Kupriyanov; N S Smetanina; G A Novichkova
Journal:  Eur Radiol Exp       Date:  2020-04-17

9.  High ferritin levels have major effects on the morphology of erythrocytes in Alzheimer's disease.

Authors:  Janette Bester; Antoinette V Buys; Boguslaw Lipinski; Douglas B Kell; Etheresia Pretorius
Journal:  Front Aging Neurosci       Date:  2013-12-06       Impact factor: 5.750

10.  Autopsy relevance determining hemochromatosis: Case report.

Authors:  Sigitas Chmieliauskas; Dalius Banionis; Sigitas Laima; Gerda Andriuskeviciute; Sandra Mazeikiene; Jurgita Stasiuniene; Algimantas Jasulaitis; Sonata Jarmalaite
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.